DOP73 Efficacy and safety of escalation to tofacitinib 10...

Journal of Crohn's and Colitis 2020 / 01 Vol. 14; Iss. Supplement

DOP73 Efficacy and safety of escalation to tofacitinib 10 mg BID for patients with UC following loss of response on 5 mg BID maintenance therapy: Results from OCTAVE open-label, long-term extension study

Sands, B E, Moss, A C, Armuzzi, A, Marshall, J K, Lindsay, J O, Sandborn, W J, Danese, S, Zeroncio, M, Modesto, I, Salese, L, Lawendy, N, Zhang, H, Su, C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjz203.112
Date:
January, 2020
File:
PDF, 600 KB
2020
Conversion to is in progress
Conversion to is failed